HOME Research Insight Illumina (US), Thermo Fisher (US), and QIAGEN (Netherlands)—Major Players in the Global Epigenetics Market

Illumina (US), Thermo Fisher (US), and QIAGEN (Netherlands)—Major Players in the Global Epigenetics Market

The global epigenetics market is projected to reach USD 1,605.7 Million by 2022 from USD 854.0 Million in 2017, at a CAGR of 13.5% from 2017 to 2022. Favorable government funding initiatives for epigenetics research, increasing research activities, decreasing sequencing costs & time, and rising prevalence of cancer are the key factors driving market growth

Key players in the global epigenetics market, such as Illumina, Thermo Fisher, Diagenode, Merck Millipore, Abcam, Active Motif, New England Biolabs, Agilent, Zymo Research, and PerkinElmer, are focusing on increasing their presence in the high-growth markets through organic as well as inorganic strategies such as product launches, partnerships, agreements, collaborations, expansions, and acquisitions.

Illumina dominated the global epigenetics market in 2016. The company provides sequencing and array-based solutions for genetic analysis. It develops, manufactures, and markets integrated systems and life science tools for the analysis of genetic variation and biological function. Illumina operates through 26 subsidiaries located in the US, the UK, and other countries in Europe and the Asia Pacific regions. In order to achieve high growth and increase its customer base, the company focuses on organic and inorganic strategies such as product launches, collaborations, and agreements. For instance, in January 2017, Illumina launched a NovaSeq instruments series. During the same period, the company entered into a collaboration agreement with Philips (Netherlands) to integrate its sequencing systems with Philips’ IntelliSpace Genomics clinical informatics platform for oncology.

Thermo Fisher is another prominent player in the epigenetics market. The company develops and manufactures high-end analytical instruments, laboratory equipment, software, consumables, reagents, and services for scientific research, analysis, discovery, and diagnostics. It operates in more than 180 countries across North America, Europe, Asia, Middle East, Africa, and Latin America. To strengthen its position in the epigenetics market, the company pursues organic as well as inorganic growth strategies. For instance, in June 2017, the company expanded its mass spectrometers portfolio with the launch of the Q Exactive HF-X Hybrid Quadrupole Orbitrap. Similarly, in September 2016, the company opened its new global headquarters at 168 Third Avenue in Waltham, Massachusetts (US).

Related Reports:

Epigenetics Market by Product (Kit, Enzymes, Reagent, NGS, Mass Spectrometer, PCR, Bioinformatics), Application (Oncology, Cardiology, Immunology), Technology (DNA Methylation, Histone Modification), End User (Academic, CRO) - Global Forecast to 2022

Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support

US : 1-888-600-6441

Search reports